Cardiac Allograft Gene Expression Profiling Test System
The Cardiac Allograft Gene Expression Profiling Test System is an in vitro diagnostic multivariate index assay (IVDMIA) test service performed in a single laboratory that analyzes RNA gene expression profiles from peripheral blood mononuclear cells to aid in identifying heart transplant recipients with stable allograft function who have a low probability of moderate or severe acute cellular rejection at the time of testing, used alongside standard clinical assessment. Classified as FDA Class 2 under regulation 21 CFR 862.1163 within the Cardiovascular medical specialty, it requires a 510(k) premarket notification. The product code is OJQ. It is not flagged as an implant or life-sustaining device.
Research product code OJQ in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- OJQ
- Device Class
- FDA class 2
- Regulation Number
- 862.1163
- Medical Specialty
- Cardiovascular
- Review Panel
- CH
- Submission Type
- 1
Device Characteristics
Definition
In vitro diagnostic multivariate index assay (ivdmia) test service, performed in a single laboratory, for assessing the gene expression profile of rna isolated from peripheral blood mononuclear cells (pbmc) and indicated for use to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (acr) at the time of testing in conjunction with standard clinical assessment.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 2 510(k) clearances via K numbers.
FEI Numbers
This FDA classification entry is associated with 1 FEI number. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 1 registration number. Click on an entry to view related FDA registrations.